Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by RichyRich$on Feb 10, 2014 9:38pm

217 Views

Post# 22193558

Cell Pouch Efficacy Results Expected Early 2014 ...

I re-read "Game Changing Diabetes Breakthrough in 2014?" written Dec. 15, 2013 and bottom of Pg. 1 says "Efficacy results are expected from the Cell Pouch System™ Phase I/II clinical study early in 2014." I read on another site that Sernova Fiscal Year Report is February 28, 2014. Possibly some efficacy result news on that fiscal year report.
Hang on everyone and don't do anything stupid by selling right before the efficacy results!
https://aheadoftheherd.com/Newsletter/2013/Game-Changing-Diabetes-Breakthrough-in-2014-2.html

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property